Original languageEnglish
Article number6087
JournalCancers
Volume14
Issue number24
DOIs
Publication statusPublished - 1 Dec 2022

    Research areas

  • bevacizumab, child, low grade glioma, optic pathway glioma, progression, systemic anticancer therapy, toxicity, visual acuity, visual function, visual outcome

ID: 33016215